1. Home
  2. FLGC vs HBIO Comparison

FLGC vs HBIO Comparison

Compare FLGC & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGC
  • HBIO
  • Stock Information
  • Founded
  • FLGC 2019
  • HBIO 1901
  • Country
  • FLGC United States
  • HBIO United States
  • Employees
  • FLGC N/A
  • HBIO N/A
  • Industry
  • FLGC Biotechnology: Pharmaceutical Preparations
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • FLGC Health Care
  • HBIO Industrials
  • Exchange
  • FLGC Nasdaq
  • HBIO Nasdaq
  • Market Cap
  • FLGC 17.3M
  • HBIO 16.9M
  • IPO Year
  • FLGC 2021
  • HBIO 2000
  • Fundamental
  • Price
  • FLGC $0.58
  • HBIO $0.38
  • Analyst Decision
  • FLGC Strong Buy
  • HBIO Buy
  • Analyst Count
  • FLGC 3
  • HBIO 2
  • Target Price
  • FLGC $5.00
  • HBIO $4.50
  • AVG Volume (30 Days)
  • FLGC 167.1K
  • HBIO 361.4K
  • Earning Date
  • FLGC 05-13-2025
  • HBIO 05-06-2025
  • Dividend Yield
  • FLGC N/A
  • HBIO N/A
  • EPS Growth
  • FLGC N/A
  • HBIO N/A
  • EPS
  • FLGC N/A
  • HBIO N/A
  • Revenue
  • FLGC $59,505,000.00
  • HBIO $94,135,000.00
  • Revenue This Year
  • FLGC $4.28
  • HBIO N/A
  • Revenue Next Year
  • FLGC N/A
  • HBIO $8.58
  • P/E Ratio
  • FLGC N/A
  • HBIO N/A
  • Revenue Growth
  • FLGC N/A
  • HBIO N/A
  • 52 Week Low
  • FLGC $0.42
  • HBIO $0.36
  • 52 Week High
  • FLGC $2.11
  • HBIO $4.08
  • Technical
  • Relative Strength Index (RSI)
  • FLGC 52.41
  • HBIO 30.36
  • Support Level
  • FLGC $0.49
  • HBIO $0.56
  • Resistance Level
  • FLGC $0.63
  • HBIO $0.42
  • Average True Range (ATR)
  • FLGC 0.06
  • HBIO 0.05
  • MACD
  • FLGC 0.02
  • HBIO 0.02
  • Stochastic Oscillator
  • FLGC 76.19
  • HBIO 13.00

About FLGC Flora Growth Corp.

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.

Share on Social Networks: